Vetter: multi-year project to fulfill ‘need for increased downstream resources’
The expansion is taking place at the contract development and manufacturing organization’s (CDMO) Ravensburg, Germany-based facility.
“Based on our continuous growth in development support and aseptic manufacturing capacity, we have identified the need for increased downstream resources, such as secondary packaging capacity,” Markus Kirchner, corporate spokesperson, Vetter Pharma International GmbH, told Outsourcing-Pharma.comm.
“Hand in hand with the ever-increasing complexity of the development, manufacturing, and assembly/packaging processes in the injectable business segment, customers are asking for integrated solutions at their strategic CDMO partners,” he added.
The expansion is expected to be completed over the next several years and will include new fully-automated packaging lines as well as space for manual and semi-automated packaging processes.
Assembly equipment for a variety of formats will also be included, such as for pens and autoinjectors.
The company will also expand its serialization and aggregation service.
The investment strategy
The German CDMO announced a €300m investment ($335m) in September 2015 to overhaul its manufacturing network. As part of this strategy, the company has made several expansions at the Ravensburg site, which will replace its Holbeinstrasse site.
Approximately 800 employees will be migrated to the Ravensburg site by the end of the year.
A new administration building is expected to be completed by mid-year 2019.
